Ysios Capital launches €100M fund to build biotech companies from Spanish science

1. 1Identify promising biotech research at universities and research centres in Spain
2. 2Evaluate the potential for company creation and scalability
3. 3Provide funding and support for selected projects to become biotech companies
4. 4Monitor and guide the growth of the new companies

This benefits entrepreneurs and researchers in the biotech industry, particularly those in Spain, as it provides funding for company creation from university and research centre spinouts. The investment team at Ysios Capital will be involved in identifying and supporting promising biotech projects.

💡 The fund aims to create at least three new biotech companies in 2026, focusing on the riskiest stage of biotech: company creation from academic science

💡 Ysios Capital launches €100M fund to turn Spanish science into biotech companies